Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Pain, Postoperative 2Neurotoxicity Syndromes 2Neoplasms 2Colonic Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Immunodeficiency Diseases 1Paclitaxel-induced Neuropathy 1Myoma 1Mesothelioma 1Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Brain Neoplasms 1Anesthesia 1

Interventions

Pemetrexed 23Cisplatin 19Nivolumab 8Gemcitabine 7Ipilimumab 6Carboplatin 6pembrolizumab 4Bevacizumab 4tazemetostat 3durvalumab 3Fluorouracil 3Drug Therapy 3spartalizumab 2olaparib 2niraparib 2budigalimab 2belinostat 2anetumab ravtansine 2amatuximab 2Vinorelbine 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2PM 01183 2Oxaliplatin 2Imatinib Mesylate 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Cyclophosphamide 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma × Magnesium Sulfate × Clear all
NCT04481672 2022-01-11

Intravenous Magnesium in Patients Receiving Cisplatin

Dana-Farber Cancer Institute

Phase 1 Completed
5 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡